Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. (Q53487037)
Jump to navigation
Jump to search
scientific article published on 3 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. |
scientific article published on 3 April 2008 |
Statements
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. (English)
T K Kvien
1 reference
G R Burmester
1 reference
E Keystone
C G Peterfy
P P Tak
S Cohen
M C Genovese
M Dougados
M Greenwald
S Williams
D Hagerty
M W Cravets
T Shaw
3 April 2008
68
2
216-221